Comparison of sterile silicone studs and scalp infiltration with lignocaine for the attenuation of the hemodynamic and stress response to skull pin insertion during craniotomy in pediatric neurosurgical patients: a randomized controlled trial : Sterile silicone studs versus lignocaine infiltration for skull pin insertion.

Childs Nerv SystOct 28, 2026 (epub)
Clinical ResearchAnesthesiologyNeurosurgeryPediatricsOpen access

Aman Prakash, Ashwini Reddy, Rajeev Chauhan et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial compared sterile silicone studs (SSS) with lignocaine infiltration for skull pin insertion in 64 children aged 12 years or younger undergoing neurosurgery. Compared with lignocaine, SSS was associated with lower rescue fentanyl consumption (10.3 ± 7.5 µg vs. 18.5 ± 8.6 µg; P < 0.001) and fewer children requiring rescue analgesia (65.6% vs. 90.6%). Heart rate and mean arterial pressure were also higher with lignocaine at pin insertion and through 10 minutes afterward. Minor pin-site bleeding was more frequent with lignocaine, and surgeon satisfaction was higher with SSS.

Key findings

  • Rescue fentanyl consumption was 10.3 ± 7.5 µg with SSS versus 18.5 ± 8.6 µg with lignocaine (P < 0.001).
  • Rescue analgesia was required by 65.6% of the SSS group and 90.6% of the lignocaine group.
  • Heart rate and mean arterial pressure were higher with lignocaine at pin insertion and up to 10 minutes afterward.
  • Minor pin-site bleeding was more frequent with lignocaine; surgeon satisfaction was higher with SSS.

Why it matters

Skull pin insertion can provoke nociceptive and sympathetic responses in children undergoing neurosurgery. In this trial, SSS was associated with lower opioid rescue use and less hemodynamic response than lignocaine infiltration, making it a potentially useful non-pharmacological approach to study further. The findings are relevant to perioperative analgesia and hemodynamic management, but do not establish safety conclusively.

What to keep in mind

The trial included 64 children, and the authors state that larger multicenter trials are needed to establish SSS safety conclusively.

Source

Published in Childs Nerv Syst. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Anesthesiology

Clinical ResearchOncology (Medical)

Curative-intent management of de novo metastatic nasopharyngeal carcinoma: an evidence-based consensus guideline from the International Collaborating Oncology Organisations.

This international consensus guideline addresses curative-intent management of de novo metastatic nasopharyngeal carcinoma, a population historically treated with palliative intent.

Lancet OncolOct 29, 2026Read summary
Clinical ResearchHematology

Decitabine plus busulfan-cyclophosphamide versus busulfan-cyclophosphamide myeloablative conditioning before allogeneic haematopoietic stem cell transplantation for reducing risk of relapse in adult KMT2A‑rearranged leukaemia in China: an open-label, multicentre, randomised phase 3 trial.

This open-label, multicentre, randomised phase 3 trial compared decitabine plus busulfan-cyclophosphamide (DAC-BuCy) with BuCy conditioning before allogeneic HSCT in 130 patients aged 14–65 years with KMT2A-rearranged…

Lancet HaematolOct 30, 2026Read summary
Clinical ResearchPediatrics

Prone positioning and high-frequency oscillatory ventilation in early paediatric acute respiratory distress syndrome (PROSpect): an international, two-by-two factorial, response-adaptive, phase 3, randomised controlled trial.

PROSpect was an international, two-by-two factorial, phase 3 randomised controlled trial comparing prone with supine positioning and high-frequency oscillatory ventilation (HFOV) with conventional mechanical ventilation…

LancetOct 30, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.